Authors:BHOPINDER SINGH, RAJIV DOLE, MANPREET SINGH Pages: 1 - 5 Abstract: Dusta vrana management is a common problem, encountered by medical practitioners all over the globe, that is, non-healing chronic ulcer. Without early and optimal intervention, the wound can rapidly deteriorate and leading to amputation of the affected limb. Studies reveal that it is difficult to achieve the complete aim of wound management with a single drug. In the present study, Vipareeta Malla Taila is selected from Bhaishajaya Ratnavali and Yogaratnakar. It consists of Sindoor, Kushta, Hingu, Rason, Chitrka Root, Langali, Hartal, Sharpunka, Shudh Tutha, Shudh Samundrafena, etc. These drugs having properties of Vrana Shodhana (cleansing), Ropana (healing), Vedanashamana (analgesic), Shothaharana (anti-inflammatory and reducing swelling) and bactericidal. It is a single-blind clinically study where 20 patients were selected. The patient would were treated with Vipareeta Malla Taila. Vipareeta Malla Taila mentioned by Acharya Yogratnakar in the context of Vrana chapter is found efficacious in wound healing. The drug initially acts as a debriding agent removing slough and necrotic tissues and subsequently paves way for smooth and uninterrupted healing of the ulcer. Topical application of Vipareeta Malla Taila reduces pain, burning sensation, and itching. It also decreases discharge, edema, and also helps in gradual improvement in floor and granulation tissue. The semi-occlusive dressing of Vipareeta Malla Taila provides moist environment which enhances epithelialization, prevents scab formation, and can be easily removed from wound surface without causing pain or damage to the new growing epithelium. Hence, from the present clinical study, it can be speculated that Vipareeta Malla Taila possesses sufficient efficacy in Vrana Shodana and Vrana Ropana without producing any adverse effects. PubDate: 2022-07-05 DOI: 10.22159/ijas.2022.v10i2.43258
Open Access journal
